Ultrahuman Photon: Red Light Therapy for Diabetics — Science or Hype?

Ultrahuman just launched the Photon — a ₹24,999 red light therapy device that claims to help with skin healing, muscle recovery, and collagen production. For Indian diabetics dealing with slow wound healing, neuropathy pain, and circulation issues, red light therapy sounds like a miracle cure. But is the science real or just wellness marketing?

We dove deep into the peer-reviewed research to give you the honest answer.

What Is Red Light Therapy?

Red light therapy (RLT), also called photobiomodulation, uses specific wavelengths of red (660nm) and near-infrared (850nm) light to stimulate cellular function. The theory is simple: light penetrates the skin and boosts mitochondrial activity (the cell's power plants), which increases ATP production and reduces inflammation.

The basic mechanism:

• Red light (660nm) — penetrates skin, stimulates collagen, speeds wound healing
• Near-infrared (850nm) — penetrates deeper into muscle and tissue, reduces inflammation, aids recovery

Ultrahuman's Photon combines both wavelengths in a compact handheld device. It's not a medical device — it's a "wellness device" that integrates with their Ring PRO to provide personalized therapy protocols based on your recovery data.

What the Science Actually Says About RLT for Diabetics

1. Diabetic Wound Healing — SOME EVIDENCE ✅

This is the most promising area. Diabetic wounds (especially foot ulcers) are a serious complication: 15% of diabetics develop foot ulcers during their lifetime, and they heal slowly due to poor circulation and nerve damage.

Research highlights:

• A 2021 meta-analysis in Lasers in Medical Science found RLT accelerated wound closure by an average of 43% in chronic wounds
• A 2020 study in Wound Repair and Regeneration showed near-infrared light improved collagen synthesis in diabetic mouse models
• A 2022 clinical trial in Journal of Diabetes Research demonstrated that adjunctive RLT reduced diabetic foot ulcer healing time by ~30%

But key caveats: most studies used higher power densities than consumer devices (typically 50-100 mW/cm²), and were administered by healthcare professionals over 6-12 sessions. The Photon delivers much lower intensity at home.

Verdict: There's genuine scientific basis for RLT helping diabetic wound healing. But the consumer devices available today (including Photon) are likely 3-10x less powerful than clinical devices. Results would be modest at best.

2. Peripheral Neuropathy — MIXED RESULTS ⚠️

Diabetic peripheral neuropathy affects 50-60% of diabetics, causing pain, tingling, and numbness in feet and hands. The theory that RLT could help is compelling — reduced inflammation should theoretically reduce nerve pain.

Research highlights:

• A 2019 study in Journal of Clinical Neuroscience found transdermal low-level light therapy reduced neuropathic pain in 68% of participants
• A 2021 RCT in Photomedicine and Laser Surgery showed significant improvement in nerve conduction velocity
• However, a 2023 systematic review in Cochrane Database concluded the evidence is still "low quality" and "insufficient for clinical recommendation"

Verdict: Promising but unproven. If you have neuropathy, RLT might help with pain — but it's not a replacement for proper diabetic foot care, medication, or medical treatment.

3. Circulation — LIMITED EVIDENCE 🔴

Many diabetics hope RLT will improve blood circulation (a major concern since poor circulation drives most diabetic complications). The research here is thin.

• Some animal studies show increased blood flow after RLT exposure
• Human studies are sparse and mostly focused on dialysis patients (not diabetics specifically)
• No high-quality RCTs showing RLT improves diabetic circulation long-term

Verdict: Too early to say. The mechanism is plausible but unproven in diabetic populations.

4. Collagen and Skin Health — ESTABLISHED ✅

This is where RLT has the strongest evidence — but it's NOT diabetes-specific. Studies consistently show RLT can stimulate collagen production and improve skin texture. For diabetics with thin, fragile skin (common in long-term diabetes), this could be genuinely helpful.

But here's the catch: you don't need a ₹24,999 device for this. Dermatology clinics use more powerful RLT, and even affordable consumer devices from brands like CurrentBody or Dr. Dennis Gross at ₹15,000-₹20,000 have shown clinical results.

Verdict: RLT does help skin health. But the Photon's premium price and Ultrahuman branding are adding a "health tech tax" on established technology.

What the Photon Actually Does

Let's be clear about what the Photon is and isn't:

Is the Photon Worth ₹24,999 for Diabetics?

Here's my honest take as someone who researches diabetes technology for a living:

No.

Not because RLT doesn't have benefits — it does. But because:

1. ₹24,999 is expensive for a device that delivers 3-10x less power than clinical RLT devices
2. It's positioned as a wellness device, not a medical device — no clinical trials on diabetics specifically
3. Your money is better spent on proven diabetes management: CGM sensors, quality medication, proper nutrition
4. The "personalized protocols" based on Ring data is marketing, not science. Sleep data doesn't meaningfully change how red light affects wound healing

If you want to try red light therapy as a diabetic:

• Ask your doctor first (especially if you have neuropathy)
• Consider a clinical RLT session at a dermatology/wound care clinic first (many offer trial sessions)
• Consumer RLT devices start at ₹15,000 (CurrentBody, Dr. Dennis Gross) with more research behind them
• Never use RLT as a substitute for proper diabetic wound care

The Bigger Picture: Ultrahuman's Wellness Ecosystem

The Photon represents Ultrahuman's strategy: build a wellness ecosystem around diabetics and health enthusiasts, not a diabetes management ecosystem. It's the same play Apple makes with the Apple Watch — make it aspirational, make it beautiful, make people buy the whole ecosystem.

For wealthy Indian diabetics who already have their glucose under control, the Photon might be a fun wellness add-on. But for the 90% of diabetics who are still struggling with basic glucose management? That ₹24,999 is ₹24,999 in CGM sensors or diabetes coaching that will actually impact your blood sugar.

Red light therapy is not a scam — it has real science behind it. But for diabetes management specifically, it's at best a marginal wellness add-on, not a diabetes tool.

Bottom Line

The Ultrahuman Photon is a real product with real technology. But it's positioned as a diabetes solution when it's actually a general wellness device. For Indian diabetics managing Type 1 or Type 2, skip it and invest in what the science actually proves helps: glucose monitoring, medication adherence, and proper nutrition.

Red light therapy might help your skin. But it won't save your feet. Only proper diabetic foot care and glucose control will do that.